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Abstract
Objectives Lower limb deep venous thrombosis (DVT) is a
common condition with high morbidity and mortality. The
aim of the study was to investigate the temporal evolution of
the acute thrombus by magnetic resonance imaging (MRI)
and its relationship to venous recanalization in patients with
recurrent DVTs.
Methods Thirteen patients with newly diagnosed lower limb
DVTs underwent MRI with non-contrast MR venography
(NC-MRV) and MR direct thrombus imaging (MR-DTI), an
inversion-recovery water-selective fast gradient-echo acquisi-
tion. Imaging was performed within 7 days of the acute throm-
botic event, then at 3 and 6 months.
Results By 3 months from the thrombotic event a third of the
thrombi had resolved and by 6 months about half of the cases
had resolved on the basis of vein recanalisation using NC-
MRV. On the initial MR-DTI acute thrombus was clearly
depicted by hyperintense signal, while the remaining thrombi
were predominantly low signal at 3 and 6 months. Some re-
sidual thrombi contained small and fragmented persisting hy-
perintense areas at 3 months, clearing almost completely by
6 months.
Conclusions Our study suggests that synergistic venous as-
sessment with combined NC-MRV and MR-DTI is able to
distinguish acute venous thrombosis from the established
(old) or evolving DVT detected by ultrasound.
Key Points
• MRI can distinguish between acute and evolving or chronic
lower limb DVT
• Two advanced MRI techniques can follow the evolution of
lower limb DVT
• MRI could be used to avoid an incorrect diagnosis of recur-
rent DVT
•MRI could help avoid the risks and complications of lifelong
anticoagulation therapy
Keywords Magnetic resonance imaging . Venous
thrombosis . Diagnosis . Longitudinal study . Clinical
decision-making
Abbreviations
ADVANCE-
MRV
Acceleration-dependent vascular anatomy for
non-contrast-enhanced MR venography
CUS Compression ultrasonography
DVT Deep venous thrombosis
MR-DTI Magnetic resonance direct thrombus imaging
NC-MRV Non-contrast MR venography
Introduction
Lower limb deep venous thrombosis (DVT) is a common
condition with high morbidity and mortality encountered both
in community and hospital care [1]. Despite current
anticoagulation-based treatments, the recurrence rate after a
first episode of DVT remains high, ranging between 20 %
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and 40 % [2–4]. Current management of a recurrent DVT is
lifelong anticoagulation therapy, bringing with it both the ad-
ditional cost and the burden of monitoring, as well as the well-
recognized risks related to haemorrhage. These risks have to
be balanced against the progression of a DVT with further
complications such as pulmonary emboli that, in an important
minority of cases, may be fatal [2, 4].
A clinically suspected DVT, often based on a positive D-
dimer test and clinical scoring systems, is evaluated and
followed up by compression ultrasound (CUS), now consid-
ered the standard diagnostic imaging test for lower limb DVT
for the popliteal vein and above [5–8]. An acute symptomatic
DVT is confirmed by CUS through the lack of compressibility
of the common femoral, femoral and/or popliteal veins.
However, the clinical presentation and diagnosis can be com-
plicated by often ill-defined and occasionally absent symp-
toms that may accompany thrombus formation. In addition,
many patients do not undergo follow-up imaging to confirm
whether the affected vessels have fully or partially recanalised
or remain occluded with chronic organized thrombus and in-
creased collateral venous flow providing venous return.
Compression ultrasound has proven to be a simple,
non-invasive, highly accurate, safe and cost-effective
technique with high sensitivity and specificity of 89–
100 % and 87–100 %, respectively, for DVT of the pop-
liteal vein and above in symptomatic patients [4, 9].
Despite all its advantages, CUS cannot reliably determine
the age of a thrombus and thus distinguish an acute recur-
rent DVT from a persisting previous thrombus in the same
location. Interpretation of CUS findings is further compli-
cated by the persistence of US abnormalities after the
initial episode (80 % of patients after 3 months and
50 % of patients after 1 year from initial DVT diagnosis)
[4, 7, 10, 11]. Quantitative thrombus measurements have
been proposed as a way to distinguish between new and
recurrent DVT that, although with poor interobserver
agreement in initial studies, have improved in recent pub-
lications [12, 13]. However, limited information remains
available on the temporal evolution of an acute thrombus
and our ability to distinguish between a resolving (old) or
recurring (new) DVT.
Magnetic resonance direct thrombus imaging (MR-DTI)
has been proposed as an alternative that may help establish
thrombus age and distinguish between an acute recurrent
thrombus and a persisting (evolving) clot in the same location
[14–19]. Several studies have shown that MR-DTI is a highly
accurate diagnostic test for an acute symptomatic DVT [14,
15]. The technique is based on the paramagnetic properties of
methaemoglobin, formed in a fresh thrombus, which de-
creases the longitudinal relaxation time (T1), resulting in high
signal on T1-weighted images. The MR-DTI highlights this
bright thrombus signal by nulling the signals from fat (using a
water-selective excitation) and blood (due to its long T1). The
technique has been shown to have a high sensitivity and spec-
ificity for proximal DVT of the lower limbs (sensitivity 97–
100 %; specificity 100 %) and good reproducibility [18–20].
Non-contrast MR venography (NC-MRV) has also been
shown to be effective in demonstrating the peripheral venous
system and diagnosing DVT in the thigh through visualization
of filling defects within the venous lumen [21]. However, this
technique alone cannot reliably distinguish between an acute
and an evolving thrombus, as both of these entities will appear
as intraluminal filling defects.
The aim of this study was to evaluate the temporal
changes that occur in T1-weighted signal intensity and
venous morphology in patients with a first acute DVT
using combined MR-DTI and NC-MRV at three different
time points after diagnosis. The understanding of the tem-
poral evolution, as well as the accurate diagnosis of an
acute thrombus, is clinically important, as it may help
distinguish between a new clot (formed at or adjacent to
the site of a previous DVT) and an evolving (old) throm-
bus, directly informing the clinical decision of lifelong
anticoagulation in patients with recurrent DVT.
Materials and methods
Patients
Thirteen patients (mean age 61 years, range 18–78 years; M/F
= 11:2) with ultrasound-proven above-knee DVT (in the fem-
oral vein and/or proximal popliteal vein) and no previous his-
tory of venous thrombosis or contraindications for MRI were
recruited from the DVT service in our institution. The local
ethics committee approved the study and all patients gave
informed consent before undergoing MR imaging. The initial
diagnosis of DVT was made on CUS by experienced
sonographers as part of routine standard of care. Following
patient recruitment, a member of the research team with ultra-
sound experience repeated the CUS study and the following
parameters were recorded: the date/time of onset of symp-
toms, the patient’s (pro-thrombotic) risk factors, the length
of thrombus and its relationship to the inguinal ligament and
knee joint space. CUS was also performed at 3 months (visit
2) and 6 months (visit 3) on the same day as the MRI follow-
up. On these visits, CUS was only used to establish the pres-
ence of the thrombus.
MR imaging was performed on a 1.5-T scanner (Discovery
MR450, GE Healthcare, Waukesha, WI) using a 12-channel
phased array coil. The first examination (visit 1) was within
7 days of diagnosis, and further examinations were performed
after 3 months (visit 2) and 6 months (visit 3). During this 6-
month period all the patients received standard anticoagulant
therapy (warfarin) in accordance with local protocols.
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MR examination
For each examination, NC-MRV was acquired using
Acceleration-Dependent Vascular Anatomy for Non-Contrast-
Enhanced MR Venography (ADVANCE-MRV) [22, 23]. This
technique uses subtraction of velocity- and acceleration-
dependent angiography methods, as described previously [24,
25]. Dark-vein images are subtracted from bright-vein images
to obtain vein-only images. The bright-vein images were ac-
quired using an acceleration-sensitized acquisition to suppress
the arterial blood, without suppressing venous blood [22, 23].
The dark-vein (velocity-sensitized) images were acquired using
two consecutive velocity-sensitization modules with differing
effective first gradient moments [22, 23]. To further ensure good
venous suppression, four of these dark-vein image volumes were
automatically acquired together and combined to give homoge-
neous venous signal [22, 23]. The effective first gradient mo-
ments used to generate the dark-vein image volumes were 1.2,
0.6, 0.3 and 0.15 μTs2/m. Additionally, a bright-artery image
volume was acquired and used to generate an artery-only image
volume by automated subtraction of the dark-artery (bright vein)
images described above.
For these acquisitions, the image readout was a 3D balanced-
SSFP (oblique coronal orientation, flip angle 65°, echo time (TE)
1.7 ms, repetition time (TR) 3.7 ms, acquisition matrix 288 ×
288 × 20, reconstruction matrix 512 × 512 × 40, field of view
(FoV) 40 × 40 cm, slice thickness 2.4 mm). The acquisition
was cardiac gated using peripheral-pulse triggering with a trigger
delay set to peak arterial flow. Parallel imaging (ASSET) was
usedwith an acceleration factor of 2. The acquisition timewas 40
heartbeats per volume, or 240 heartbeats for one bright-vein, four
dark-vein and one bright-artery image volumes. To avoid flow
and heterogeneity-related artefacts near the edges of the field of
view, two separate acquisitions covering the upper and lower
halves of the thigh were performed, with a combined acquisition
time of 480 heartbeats (8 min at 60 bpm). Based on the above
matrix sizes, the acquired and reconstructed voxel dimensions
were 1.38 × 1.38 × 2.4 mm3 and 0.78 × 0.78 × 1.2 mm3
respectively.
MR-DTI was performed using a 3D inversion-prepared
fast gradient-echo acquisition with a water-selective excitation
(1-2-1 binomial pulse sequence). The image volumes were
acquired in coronal orientation and the image parameters were
optimized by numerical simulation to ensure high signal from
short-T1 thrombus while suppressing the signal from long-T1
blood [26]. The acquisition used centric k-space ordering,
acquiring half the slice-encodes from each read-slice k-space
plane per shot. The acquisition parameters were inversion time
(TI) 340 ms, TE 6.3 ms, TR 12.2 ms, flip angle 25°, centric
ordering, acquisition matrix 320 × 288 × 96, FoV 40 ×
40 cm2, slice thickness 2 mm, 320 ms delay after each shot.
Parallel imaging (ASSET) was used with an acceleration fac-
tor of 2. Zero-filling interpolation was used in-plane to give a
reconstructed volume size of 512 × 512 × 96. The acquisition
time was 5 min 59 s.
MR image analysis
The MR-DTI volumes were reformatted to match the NC-
MRV images. An experienced radiologist (DJL) assessed the
NC-MRV images using an Osirix workstation (Pixmeo,
Berne, CH) to determine the location and length of the venous
occlusion (complete or partial, above-knee only). This assess-
ment was performed principally using the subtracted NC-
MRV images; however, the arterial images, as well as the
Fig. 1 Images for an example
patient showing the evolution of
the thrombus signal. The NC-
MRV image (a composite MIP
from the two table positions)
shows an occluded right femoral
vein at all three time-points, but
the thrombus is visible on MR-
DTI only for the first
examination. MR-DTI images are
shown as curved-plane reformats
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unsubtracted bright- and dark-vein images, were also avail-
able to aid the diagnosis where needed.
Subsequently, an assessment of the location and length of
any high-signal regions on the matchingMR-DTI images was
performed and these were compared with the NC-MRV im-
ages to evaluate to what extent thrombus length and location
matched on both techniques. The individual-slice images were
evaluated with reference to curved-reformat images, as re-
quired where the thrombi curved significantly out of the image
plane. Any mismatch in thrombus extent or location was re-
corded. All discontinuities in high signal T1 regions were
noted and the tract lengths were summed over the affected
region on the matching NC-MRV.
Results
The femoral vein occlusion by thrombus was identified in all
cases on NC-MRV and matched the ultrasound findings for
location and extent. The thrombus length was between 6.4 and
40.0 cm (mean 27.7 cm) on the first visit. On visit 2, thrombus
was no longer present in 4/13 cases, had reduced in length in a
Fig. 2 MIP images of the NC-
MRV showing an occluded right
femoral vein at all three visits;
curved-plane reformats of the
MR-DTI show the whole
thrombus at visit 1, but only tiny
fragments at visit 2 (arrows)
Fig. 3 Measured lengths on NC-MRVand MR-DTI images. The darker
colours for each patient and visit correspond to the measurements
performed on MR-DTI images (bottom bars) while the NC-MRV
measurements are illustrated in lighter colours (upper bars). If, in the
same visit, the MR-DTI and NC-MRV measurements were identical,
the MR-DTI value only was presented. If only NC-MRV values are
shown then no measurable segment was seen on MR-DTI images
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further 6/13 cases (range 3.8–30.3 cm, mean 15.9 cm) and was
unchanged in the remaining three cases (range 32.4–39.0 cm).
On visit 3, only 6/13 cases still had thrombus present (range
17.9–39.0 cm, mean 30.4 cm). Figures 1 (patient G) and 2
(patient C) show NC-MRV and MR-DTI images in two pa-
tients with venous occlusion on all three visits, while Fig. 3
shows the measured lengths of the occluded region on the NC-
MRV and the corresponding MR-DTI images for each visit
and each patient. All thrombus length measurements are sum-
marized in Table 1.
On the first visit, high signal at MR-DTI was found to
match spatially the NC-MRV-defined occlusion in all but
one case. This exception case (patient I) is shown in Fig. 4
and is discussed below. On the subsequent second and third
visits, the thrombus was either not visualized or only small/
fragmented bright signal areas were seen on MR-DTI—less
than 29 % (visit 2) and 3 % (visit 3) of the original thrombus
length. The case with most residual bright thrombus signal on
visits 2 and 3 is shown in Fig. 5 (patient L). Recanalisation, as
assessed on the NC-MRV images, occurred in seven patients,
but in six patients the superficial femoral vein remained par-
tially or completely occluded.
Discussion
Our study is in line with previous work and confirms the poten-
tial value of MR-DTI in the diagnosis and follow-up of acute
DVT involving the femoral and proximal popliteal veins by de-
tecting the presence and changes in methaemoglobin content of
the recently formed thrombus [18]. It demonstrates that by
3 months from the thrombotic event about a third of the thrombi
had resolved and by 6 months only about half of the cases had
residual thrombus present. When following the evolution of
methaemoglobin changes over time, at 3 months less than half
of the patients showed persistent, albeit small and fragmented,
hyperintense areas at the site of the thrombus that almost
completely cleared at the 6-month MR-DTI examination, con-
sistent with the expected evolution of methaemoglobin.
The length and location of the thrombus matched in all
patients on the NC-MRV and MR-DTI images on the first
visit, except in one case (patient I shown in Fig. 4). In this
patient, the proximal and distal ends of the thrombus were
clearly depicted on both the NC-MRV and MR-DTI images,
but the MR-DTI signal was discontinuous distally in the re-
gion of the knee. However, the extent of thrombus could still
Table 1 NC-MRV (MRV-) and
MR-DTI (MRDTI-) lengths (cm)
in all patients and visits
Visit Visit 1 (0 months) Visit 2 (3 months) Visit 3 (6 months)
Patient MRV-1 MRDTI-1 MRV-2 MRDTI-2 MRV-3 MRDTI-3
Patient A 37 37 30.3 2.9 30.3 0.5
Patient B 17.1 17.1 0 0 0 0
Patient C 36 36 36 1.5 36 0
Patient D 33.5 33.5 4.5 0.5 0 0
Patient E 7.6 7.6 0 0 0 0
Patient F 6.4 6.4 3.8 0 0 0
Patient G 32.4 32.4 32.4 0 32.4 0
Patient H 32.2 32.2 26.7 0.7 26.7 0
Patient I 25.4 20.7 0 0 0 0
Patient J 18.04 18.04 0 0 0 0
Patient K 39 39 39 0 39 0
Patient L 34.9 34.9 25 9.9 17.9 1
Patient M 40 40 4.9 1.3 0 0.3
Fig. 4 MR-DTI (curved-plane reformat) of the only case where the
bright-signal region on examination 1 did not fully match the occlusion
observed on NC-MRV. The thrombus contained a dark-signal region near
the knee with bright-signal regions both proximal and distal to it. This
central dark-signal region may contain older thrombus
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be reliably measured, as an absence of flow was demonstrated
in the region of MR-DTI discontinuity.
Figure 5 (patient L) shows persistent occlusion of the vein
on all 3 visits with multiple short discontinuous hyperintense
segments remaining at 3 months (visit 2) and reducing sub-
stantially in size at 6 months (visit 3). At visit 2, this exam
contains the most high signal MR-DTI fragments of any ex-
amination in this study. These fragments are discontinuous
and are more likely to represent residual fragmented thrombi
from the initial thrombotic event, as the vein remained
completely occluded (confirmed by the NC-MRV) and the
bright foci were located more centrally in the vein as opposed
to the peripheral Bring-like^ distribution of the bright signal on
the surface of the thrombus at visit 1.
Three patients (A, L and M) had high signal intensity foci
on MR-DTI images both at 3 and 6 months. In contrast to the
other two patients (A and L) where these hyperintense frag-
ments were accompanied by occlusion on NC-MRV, patient
M showed no occlusion on the corresponding NC-MRV im-
ages. In this latter case (patient M), the bright fragments could
represent either Bresidual^ thrombus from the initial DVTor a
Bnew^ thrombus (perhaps related to an area of endothelial
damage).
Our work has several strengths.We designed a longitudinal
study to characterize the evolution of acute Bde novo^ presen-
tations of deep vein thrombosis with two non-invasive non-
contrast MR methods: a vascular technique (NC-MRV) and a
thrombus-characterization technique (MR-DTI). Despite be-
ing challenging to implement because of the complexities of
arterial and venous haemodynamics, we were able to perform
these techniques within the constraints of a clinical workflow
and acquire diagnostic quality NC-MRV and MR-DTI in a
clinically acceptable examination time. We successfully
confirmed the expected evolution of lower-limb DVT in the
majority of patients. These findings, if confirmed in a larger
cohort study, could improve the diagnosis of recurrent DVT
that is typically treated with lifelong anticoagulation.
The limitations of this study are the small number of pa-
tients and the use of compression US alone as the Bgold
standard^ for thrombus detection (as invasive venogram stud-
ies are no longer performed for DVT diagnosis in our clinical
practice). The recruitment criteria were designed to avoid pa-
tients with prior DVT but it is possible that an asymptomatic
DVT may have occurred previously in our population as
discussed regarding patient I.
Future work will concentrate on further optimization of this
technique, expanding the number of patients and investigating
the relationships between the observed small MR-DTI
hyperintensities and the clinical evolution and risk profile of
these patients.
MR-DTI, in combination with other methods such as NC-
MRV or US, may in future prove to be a valuable tool for
distinguishing between acute and chronic thrombus in cases
of suspected recurrence, potentially improving clinical
management.
Conclusion
This initial study demonstrates that, in patients with a lower
limb DVT, consistency between MR-DTI and NC-MRVeval-
uations of thrombus size and location suggests that the throm-
bus is acute, while a large discrepancy, or absence of high
signal on MR-DTI for NC-MRV-observed thrombi, suggests
an older, pre-existing thrombus. These non-invasive MRI
techniques used in patients with symptoms of lower limb
Fig. 5 MR-DTI images at all three time-points for the case showing
bright-signal fragments at visit 2 (3 months). Transverse reformats
demonstrate that these fragments are located in the centre of the
thrombus, suggesting that they represent evolution of the existing
thrombus rather than development of new thrombus. In contrast, the
hyperintense signal for the early time-point (visit 1) occurs around the
edge of the thrombus
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DVT might help in future avoid an incorrect diagnosis of
recurrent DVT thereby avoiding the risks and complications
associated with lifelong anticoagulation therapy.
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